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This review surveys the recent literature on the neurodevelopmental impacts of chemical exposures during pregnancy. The re-
view focuses primarily on chemicals of recent concern, including phthalates, bisphenol-A, polybrominated diphenyl ethers, and 
perfluorinated compounds, but also addresses chemicals with longer histories of investigation, including air pollutants, lead, 
methylmercury, manganese, arsenic, and organophosphate pesticides. For some chemicals of more recent concern, the available 
literature does not yet afford strong conclusions about neurodevelopment toxicity. In such cases, points of disagreement among 
studies are identified and suggestions provided for approaches to resolution of the inconsistencies, including greater standardiza-
tion of methods for expressing exposure and assessing outcomes.
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Pregnancy has long been recognized as a potentially critical 
window of vulnerability for exposure to a variety of chemicals. 
This review focuses on chemicals that are thought to perturb 
fetal brain development, resulting in altered postnatal behav-
ior. These include chemicals whose risks have been known for 
millennia (e.g., lead), others for a few decades (e.g., methyl-
mercury), and others for which the first data on neurotoxicity 
in children date only from the last few years (e.g., bisphenol 
A, phthalates, polybrominated diphenyl ethers, polycyclic aro-
matic hydrocarbons, perfluoroalkyl acids). Not surprisingly, the 
chemicals differ in the depth and breadth of the data available 
on which to base a risk assessment. Although recent advances 
in our understanding of chemicals such as lead and methylmer-
cury are discussed, most of the review focuses on chemicals 
of more recent concern, for which data, though sparse, have 
stimulated concern. As will be evident, for these chemicals it is 
generally not possible to draw firm inferences at present about 
issues such as critical dose and the period(s) of greatest vulner-
ability. For some of the chemicals, such as lead, perfluoroalkyl 
acids, organophosphate pesticides (OPs), and manganese, oc-
cupation may be a significant route of exposure. For others, the 
major routes involve diet and lifestyle although the exposures 
might act synergistically with occupational exposures to in-
crease fetal neurotoxicity. Our understanding of such potential 
interactions is rudimentary at present, however.
Phthalates
Phthalates are a group of synthetic plasticizers and solvents 
that are used in a wide variety of commercial products, in-
cluding food packaging, polyvinyl chloride tubing, medical 
equipment, toys, and cosmetics. Although the mechanism of 
toxicity has not been established, animal studies suggest several 
possibilities, including perturbations of hypothalamic sexual 
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differentiation, hippocampal development, midbrain dopami-
nergic activity, thyroid homeostasis, calcium signaling, peroxi-
some proliferator-activated receptors, and lipid metabolism. It 
is prenatal exposures to phthalates that are considered to be of 
greatest concern although the critical windows of vulnerability 
for different endpoints remain to be identified. 
To date, fewer than a dozen epidemiological studies have 
been published evaluating phthalate exposure and child devel-
opment. In prospective studies, poorer outcomes in a variety of 
domains have been reported to be associated with higher prena-
tal phthalate exposures, including neonatal neurological status 
[1,2], infants’ scores on the Bayley scales [3,4], executive func-
tion [5], behavior problems [5], patterns of play [6], and social 
impairment [7]. Two cross-sectional studies reported inverse 
associations between the phthalate levels of school-age children 
and their intelligence [8] and prevalence of behaviors related to 
the attention deficit hyperactivity disorder (ADHD) [9].
Although these limited studies are consistent in suggesting 
poorer outcomes among children with higher biomarker levels 
of prenatal or concurrent phthalate exposure, it is impossible to 
draw strong inferences at this time. First, most studies included 
evaluation of many exposure-outcome associations, but, in 
general, relatively few of them reached statistical significance 
raising the prospect of an inflated rate of false positive findings. 
Second, phthalate exposure was not always expressed in the 
same way in the different studies. In some, specific metabolites 
were used in the analyses, whereas in others the sum of low- or 
high-molecular weight metabolites were used, making it dif-
ficult to compare the dose-response relationships across studies. 
Third, in some instances, studies assessed the same domain 
but used different instruments (e.g., neonatal behavioral assess-
ment system vs. the neonatal intensive care unit network neu-
robehavioral scale). Fourth, the pattern of findings sometimes 
differed. For example, in some studies, it was girls’ outcomes 
that were most strongly associated with exposure, whereas in 
others it was boys’ outcomes. In yet others, no sex differences 
were found. Although multiple studies reported that children’s 
behavior was associated with phthalate exposure, in some stud-
ies, the behavior problems were “internalizing” (i.e., anxiety, 
withdrawal), whereas in others they were “externalizing” (e.g., 
hyperactivity, aggression). Additional studies that address some 
of these issues are required before conclusions can be drawn 
about the level of risk associated with contemporary levels of 
exposure to phthalates.
Bisphenol-A (BPA)
Only a few studies have evaluated the neurodevelopmental 
impact of prenatal exposure to BPA, an organic compound 
with hormone-like properties that is used in the manufacture of 
plastics. In the study of Yolton et al. [1], neither urinary BPA 
concentration at 16 (mean 1.8 ng/mL) or 26 weeks (1.7 ng/
mL) of gestation was significantly related to infants’ neurologi-
cal status at 5 weeks of age. Miodovnik et al. [7] reported that 
urinary BPA concentration in the third trimester (mean 1.2 ng/
mL) was not significantly associated with the risk of social im-
pairment at 7 to 9 years of age. 
Three papers (two cohorts) have focused on child behav-
ior as the endpoint, and the results are consistent in general, but 
not specific, terms. Braun et al. [10,11] measured urinary BPA 
at 16 weeks, 26 weeks, and at birth in pregnant women and 
in their children at 1, 2, and 3 years of age. The median BPA 
concentrations were 2.0 μg/L during pregnancy and 4.1 in the 
children. At 2 and 3 years of age, the children’s behavior was 
assessed using a parent-completed questionnaire, the behavior 
assessment for children-2 (BASC-2). At 3 years, parents also 
completed the behavior rating inventory of executive function-
preschool (BRIEF-P). BPA concentration measured at 16 
weeks of gestation bore the strongest associations with child be-
havior at 2 years of age, particularly for externalizing problems 
(hyperactivity, aggression) and only among girls. At 3 years 
of age, significant associations were noted, in girls, between 
mean BPA concentration during gestation and ratings of some 
behavior problems, namely scores on the anxiety, hyperactivity, 
and depression scales of the BASC-2 and the emotional control 
and inhibition scales of the BRIEF-P. No associations were 
observed for boys, nor were childhood BPA concentrations as-
sociated with any of the endpoints measured. Perera et al. [12] 
also conducted a prospective cohort study, measuring urinary 
BPA in late pregnancy (34 weeks on average) and at ages 3-4 
years in the children. Parents completed the child behavior 
checklist. In this cohort, evidence of significant adverse asso-
ciations was found only in boys. Boys in the highest quartile of 
prenatal BPA concentration had worse scores than boys in the 
lower three quartiles on the emotionally reactive and aggressive 
behavior scales. Among girls, in contrast, higher prenatal BPA 
concentration was associated with better scores, with the dif-
ferences reaching significance for the anxious/depressed and 
aggressive behavior scales. The reasons for the discrepancies 
between the findings of these two studies are unknown. 
At present, the evidence regarding BPA neurotoxicity at 
levels experienced in the general population does not provide a 
consistent pattern in terms of sex differences in vulnerability or 
in the specific behavioral domains most affected. Chemicals and Children’s Neurodevelopment
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Polybrominated Diphenyl Ethers (PBDEs)
The evaluation of brominated flame retardants is complicated 
by the fact that, like polychlorinated biphenyls, there are many 
congeners that are likely to differ in their neurodevelopmental 
toxicity. As noted with respect to phthalates, studies generally 
have not characterized exposure in a way that permits the find-
ings to be compared. In a cohort of Spanish newborns [13], 
congener concentrations were measured in cord blood and 
serum at 4 years of age. Statistical analyses were limited to 
PBDE 47 because it was the only congener that could be quan-
tified in a sufficient number of samples. Concentration was 
dichotomized based on analytical rather than biological consid-
erations (above or below the limit of quantification). No score 
on the McCarthy scales of children’s abilities was significantly 
associated with either prenatal or postnatal concentration of 
PBDE 47. Higher postnatal concentration was significantly as-
sociated with teacher-reported ADHD symptoms and poorer 
social competence. In another Spanish cohort, Gascon et al. 
[14] evaluated the relationship between the sum of the concen-
trations of PBDE 47, 99, 100, 153, 154, 183, and 209 in colos-
trum and children’s scores on the Bayley scales at 12-18 months 
of age. Mental development index scores, but not psychomotor 
development index scores, decreased with increasing PBDE 
concentration, and this association appeared to be due largely 
to congener 209.
In an inner-city cohort in New York City, Herbstman et 
al. [15] measured congeners 47, 99, and 100 in cord blood and 
assessed children’s neurodevelopment at 12-48 and 72 months 
of age. Multivariate analyses indicated significant associations 
between PBDE 47 and 12-month psychomotor development 
index scores on the Bayley scales; PBDE 47, 99, and 100 and 
24-month mental developmental index scores; PBDE 100 and 
36-month mental development index scores; PBDE 47, 99, and 
100 and 48-month full-scale and verbal intelligence quotient (IQ) 
scores on the Wechsler preschool and primary scale of intelli-
gence-revised (WPPSI-R); and PBDE 100 and 72-month per-
formance IQ scores on the WPPSI-R. In a Taiwanese cohort, 
Chao et al. [16] measured 14 PBDE congeners in breast milk 
and scores at 8-12 months of age on the Bayley scales. The 
sum of the concentrations of the 14 congeners (mean of 2.92 
ng/g lipid) was not associated with any scores on the Bayley 
scales (cognitive, language, motor, social-emotional, adaptive 
behavior). However, PBDE 209 concentration was significantly 
inversely associated with score on the cognitive scale, and 
PBDE 196 was significantly positively associated with score on 
the language scale. Finally, in a cohort in California, Eskenazi 
et al. [17] evaluated associations between the sum of the con-
centrations of 47, 99, 100 and 153 during gestation and chil-
dren’s cognition, motor function, and attention at ages 5 and 7 
years. The sum was associated with poorer performance on a 
computerized continuous performance test at age 5 and with 
worse ratings on parent-completed attention questionnaires at 
ages 5 and 7. Teacher ratings of attention and other aspects of 
behavior, were not associated with gestational PBDE exposure, 
however. Higher child PBDE concentrations at 7 years were 
associated with more teacher-reported attention problems, 
but not parent ratings of such problems. Both gestational and 
concurrent PBDE concentrations were significantly inversely 
associated with scores on the verbal comprehension index of 
the Wechsler intelligence scale for children-IV, with childhood 
PBDE concentration also inversely associated with scores on 
full-scale IQ, as well as the perceptual reasoning and processing 
speed indices.
Clearly many important issues remain to be clarified, as 
the findings are not consistent across studies in terms of the 
most vulnerable developmental domains, nor in terms of which 
congeners confer the greatest neurodevelopmental risk.
Perfluorinated Compounds (PFCs)
PFCs are a group of synthetic chemicals used as surfactants, 
surface treatment chemicals, and processing aids for many 
products, including repellent coatings on carpet, textiles, 
leather, and paper. Exposure occurs through transfer from 
food packaging and preparation materials, bioaccumulation in 
the food chain, and household dust. Only a few studies have 
evaluated the potential neurotoxicity of prenatal exposures to 
PFCs. In the Danish national birth cohort, early pregnancy 
plasma perfluorooctanoate (PFOA) and perfluorooctane sul-
fonate (PFOS) levels were not related to maternal report of 
motor or mental development through age 18 months [18] or 
to maternal reports of motor coordination or behavior at age 7 
[19]. Similarly, in a community sample of children exposed to 
PFOA through contaminated water, Stein et al. [20] found that 
scores on a comprehensive battery of neuropsychological tests 
were not related to children’s serum PFOA, measured several 
years earlier, or to a modeled estimate of prenatal exposure. 
Two studies have evaluated the association between PFC 
exposures and ADHD in children. Using National Health 
and Nutrition Examination Survey data, Hoffman et al. [21] 
reported increased odds of parent-reported ADHD with higher 
serum PFC levels. In the community sample of children ex-
posed as a result of water contamination, however, reduced 
odds of parent-reported ADHD were observed at the high-
est PFOA levels and increased odds with increasing levels of Bellinger DC 
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perfluorohexane sulfonate [22]. Gump et al. [23] found higher 
levels of several PFCs, although not PFOA, were associated 
with impulsivity using a differential reinforcement of low rates 
of responding task among a cohort of 9-11-year old children. 
The current data provides only limited evidence that 
higher prenatal exposures, in non-occupational cohorts, cause 
adverse neuropsychological outcomes in children.
Air Pollution
The possibility that gestational exposure to higher levels of air 
pollution is neurotoxic to fetal brain development has been 
investigated by Perera and colleagues [24] in New York City, 
China, and Poland. In New York City, higher prenatal expo-
sure to polycyclic aromatic hydrocarbons (PAHs) (greater than 
the median air concentration of 2.26 ng/m
3) was associated 
with an IQ deficit of 4-5 points at age 5 years [24] and greater 
parent-reported behavior problems at age 6-7 years [25]. In Chi-
na, higher cord blood levels of PAH-DNA adducts were associ-
ated with lower neurodevelopmental scores at 2 years of age 
[26] but not with lower IQ scores at age 5 years except among 
children also exposed to environmental tobacco smoke [27]. In 
Poland, air PAH concentrations greater than the median during 
pregnancy (17.96 ng/m
3) were associated with lower nonverbal 
reasoning scores at age 5 years [28]. 
In a study conducted in Guatemala, Dix-Cooper et al. [29] 
found that higher exposure to carbon monoxide in the third 
trimester, a marker of exposure to woodsmoke, was associated 
with poorer scores on attention, memory, and fine motor tests 
at age 6-7 years. Cross-sectional studies of children in Mexico 
City identified several possible mechanisms of neurotoxicity, 
including increased inflammatory processes, white matter pa-
thology, and amyloid-β diffuse plaques in children [30,31].
Air pollution has only recently been recognized as a risk 
factor for neurodevelopmental toxicity, and though the findings 
reported to date give cause for concern, they cannot easily be 
integrated in terms of critical constituent(s) of air pollution, 
critical doses, and most vulnerable neurodevelopmental do-
mains.
Lead
Despite the long history of research on lead neurotoxicity, 
new evidence of adverse effects at lower and lower levels of 
exposure continues to accumulate at a rapid pace, stimulating 
numerous policy revisions. In early 2012, the US Centers for 
Disease Control (US CDC) issued guidelines for the identifica-
tion and management of elevated blood lead levels in pregnant 
women [32]. It concluded that a blood lead level of 5 μg/dL 
places a woman’s fetus at increased risk of adverse effects and 
warrants follow-up testing, patient education, and nutritional, 
environmental, and behavioral interventions to reduce lead 
exposure. Also in 2012, the US CDC abandoned use of the 
term “level of concern” with regard to childhood lead poison-
ing due to the lack of evidence that any blood lead level can 
be considered to be “safe” [33]. As an alternative, it suggested 
use of a “reference” value linked to the current distribution of 
blood lead levels in a population. The recommendation was 
that the blood lead level corresponding to the 97.5th percentile 
of the distribution be used to identify children with an unusu-
ally high blood lead level. Currently, the blood lead level corre-
sponding to this percentile in US children is 5 μg/dL, but it can 
be expected to be lower in the future as additional measures to 
reduce population exposures are implemented. 
This shift in the strategy used to identify children at in-
creased risk was motivated by recent evidence that blood lead 
levels well below 10 μg/dL are associated with outcomes such 
as reduced IQ, executive function deficits, and attention deficit 
hyperactivity disorder [34]. One of the more striking recent 
findings is that the slope of the dose-effect relationship relating 
blood lead level and neurodevelopment is nonlinear, specifical-
ly supra-linear, such that the rate of decline in children’s scores 
is greater at blood lead levels below 10 μg/dL than it is at levels 
greater than 10. For example, in the pooled analyses of 1,333 
children enrolled in 7 international prospective studies, an in-
crease from 2.4 to 10 μg/dL in childhood blood lead level was 
associated with a decline of 3.9 points in full-scale IQ, whereas 
increases from 10 to 20 and from 20 to 30 were associated with 
declines of 1.9 and 1.1 points, respectively [35]. 
A birth cohort study that involved follow-up of partici-
pants at about 30 years of age reported preliminary evidence 
that umbilical cord blood lead level is associated with amyloid-
beta levels in blood, as well as the expression of genes associ-
ated with the risk of Alzheimer’s disease [36]. This is consistent 
with the finding, in studies in rodents and non-human primates, 
that early life lead exposure predisposes to neurodegeneration 
in adulthood via epigenetic processes [37]. Use of a variety 
of magnetic resonance brain imaging modalities, including 
morphometric [38], diffusion tensor [39], magnetic resonance 
(MR) spectroscopy [40], and functional MR [41] has provided 
evidence that prenatal or early childhood blood lead levels are 
associated with a variety of adverse effects on adult brain struc-
ture, organization, and function.  Chemicals and Children’s Neurodevelopment
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Methymercury
The primary pathway of human exposure to methylmercury is 
the consumption of contaminated foods, particularly seafood 
and rice [42]. Although the devastating impact of high prenatal 
exposure to methylmercury has been recognized for decades, 
the importance of chronic low-level exposure has been contro-
versial due to the apparent conflict between the findings of the 
two largest prospective birth cohort studies, conducted in the 
Faroe Islands and the Seychelles Islands. Whereas reports from 
the Faroe Islands study have consistently identified methylmer-
cury-associated deficits in children’s neurodevelopment [43,44], 
reports from the Seychelles Islands have not [45,46]. Indeed, 
the associations found in the Seychelles study have tended to 
suggest that higher methylmercury exposure is associated with 
better child development. This discrepancy has vexed risk as-
sessors charged with establishing exposure standards. Relying 
largely on the Faroe Islands study, the US Environmental Pro-
tection Agency (EPA) established a reference dose of 0.1 μg/
kg body weight/day for methylmercury intake [47], but other 
groups, such as the US Agency for Toxic Substances and Dis-
ease Registry, relying on the Seychelles Islands study, suggested 
that a higher dose, such as 0.3 μg/kg/body weight/day, would 
be adequately protective for fetal neurotoxicity [48].
Recent studies have begun to provide some clarity regard-
ing the basis for the apparent conflict of the findings of the 
Faroe Islands and Seychelles Islands studies. The key was the 
recognition that a woman’s seafood consumption exposes her 
fetus not only to methylmercury but to nutrients that promote 
optimal development (e.g., omega-3 fatty acids, choline, seleni-
um), and that a failure to consider this in the data analysis can 
result in an underestimate of the adverse impact of mercury. 
The existence of such negative confounding is illustrated by 
analyses of a birth cohort in Boston [49,50] and by a re-analysis 
of the Faroe Islands data [51]. In a new Seychellois cohort, in 
which biomarkers of children’s nutritional status were mea-
sured, inverse associations have been found between prenatal 
methylmercury exposure and infant development when appro-
priate adjustments are made for the beneficial constituents of 
seafood [52]. 
The US EPA reference dose of 0.1 μg Hg/kg/day cor-
responds to a maternal hair mercury level during pregnancy of 
approximately 1 μg/g (or 5.8 μg/L in cord blood). The point of 
departure for deriving this value is the lower limit of the confi-
dence interval of the benchmark dose (BMD), the hair mercury 
concentration that is associated with a specified adverse effect 
(specifically a doubling of scores 2 or more standard deviations 
below the expected score). The lower limit of the BMD is then 
divided by uncertainty factors to adjust for deficiencies in the 
database. Therefore, 1 μg/g of hair mercury was not a level 
at which adverse impact was directly observed in the Faroe 
Islands study. In fact, few women in this cohort had biomarker 
levels this low (the mean was 4.27 and the inter-quartile range 
2.6-7.7). However, some recent studies do provide limited evi-
dence that prenatal exposure at levels close to the reference dose 
are associated with adverse neurodevelopment [49,50,53,54], 
including behaviors associated with ADHD disorder [55].
Worldwide, levels of methylmercury exposure vary con-
siderably due to variability in diet. The mean concentration of 
hair mercury in US women of reproductive age is 0.2 μg/g (95th 
percentile: 1.7) [56], and the mean concentration of mercury 
in blood is approximately 1 μg/L (95th percentile: 7.1) [57]. In 
Japanese women, biomarker levels are approximately 10-fold 
higher [58,59]. In a representative sample of the population of 
the Republic of Korea, the geometric mean blood mercury lev-
el was 3.2 μg/L [60]. Hair mercury levels are particularly high 
among individuals living in areas heavily impacted by artisanal 
gold mining, in which mercury is used as an amalgamator, 
eventually ending up in waterbodies, contaminating fish and 
exposing subsistence fishermen and their families [61]. These 
activities are being conducted in approximately 50 countries.
Manganese
Unlike all of the other chemicals reviewed here, manganese 
is an essential nutrient, and the potential neurodevelopmental 
consequences of manganese excess have only recently come 
under investigation. Progress in this area of investigation has 
been hampered due to the absence of a clear consensus among 
investigators regarding the best biomarker of exposure. Studies 
have relied on hair manganese, blood manganese, and water 
manganese to represent children’s exposures. Claus Henn et al. 
[62] reported an inverted U-shape relationship between blood 
manganese (mean 24.3 μg/L, standard deviation = 4.5) and 
neurodevelopment in 12 month olds, such that both manga-
nese deficiency and manganese excess were associated with 
lower scores. Water manganese level (mean 795 μg/L, range 
4-3,908) was reported to be inversely related, in a dose-related 
manner, to the IQ scores of 10-year-old Bangladeshi children 
[63]. Among 8-11 year old Bangladeshi children, achievement 
scores in mathematics were significantly lower among children 
with water manganese levels exceeding 400 μg/L, but scores in 
language skills were not [64]. In a study conducted in Quebec, 
where the water manganese levels are much lower than in Ban-
gladesh, 6-13 year-old children with higher levels of manganese 
in drinking water (mean 34 μg/L, range 1-2,700) had signifi-Bellinger DC 
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cantly lower IQ scores (6.2 point difference between the scores 
of children in the highest vs. lowest manganese quintiles) [65]. 
Elevated manganese exposure has also been reported 
to be associated with an increased risk of behavior problems 
in children. In a study of 8-11 year old Bangladeshi children, 
higher water manganese levels (mean 889 μg/L, range 40-
3,442) were associated more teacher-reported internalizing and 
externalizing behavior problems [66]. In a pilot study of 6-15 
year-olds in Quebec, Bouchard et al. [67] found that children 
with higher hair manganese levels (mean 5.1 μg/g, range 0.3-
20.0) were reported by their teachers to have more oppositional 
and hyperactive behaviors. 
A few studies have reported on the neurodevelopmental 
impact of children’s co-exposures to manganese and other con-
taminants. Wright et al. [68] found interactions between man-
ganese and arsenic such that elementary school-aged children 
with hair levels above the median value for both metals had sig-
nificantly worse verbal skills than children with levels above the 
median for only one metal. Wasserman et al. [69] did not find 
such an interaction in their Bangladesh studies, however. Claus 
Henn et al. [70] reported significant interactions between man-
ganese and lead, such that the slope of the dose-effect relation-
ship between blood lead and infant development was steeper 
among children in the highest quintile of blood manganese 
level than it was among children with lower blood manganese 
levels. A similar finding was reported by Kim et al. [71] in older 
children.
The use of different exposure biomarkers in different stud-
ies makes it difficult to compare the findings, especially those 
relating to the dose-effect relationships. As a whole, the find-
ings implicate manganese as a developmental neurotoxicant, 
but details of the relationships, including the critical windows 
of vulnerability and the most vulnerable domains, remain to be 
clarified. 
Arsenic
Developmental neurotoxicity has only recently been considered 
to be among the potential sequelae of increased arsenic expo-
sure. Many of the studies demonstrating this association have 
been conducted in Bangladesh, where wellwater can be highly 
contaminated due to the local geology. Several studies reported 
on a cohort of 1,700 children for whom urinary arsenic mea-
sures from early and late gestation (approximately 80 μg/L, 
range 37-230) and the post-natal years were available [72-74]. 
No associations were observed between arsenic levels and in-
fant development at 7 or 18 months of age, but, at 5-years of 
age, concurrent urinary arsenic, urinary arsenic in late gesta-
tion, and urinary arsenic at 1.5 years, were inversely associated 
with verbal IQ and full-scale IQ scores, but in girls only. Each 
100 μg/L increase in urinary arsenic was associated with a 
1-3 point decline in IQ score. The results of this longitudinal 
study illustrate the importance of extending follow-up beyond 
infancy, when the neurodevelopmental testing that is possible is 
limited in its validity and scope.
Several cross-sectional studies of older children, in which 
measurements or estimates of prenatal exposure were not avail-
able, have reported significant associations between children’s 
neurodevelopment and arsenic biomarkers (e.g., urine, hair) 
or concentrations in environmental media (e.g., well water) 
[66,75-78]. 
OPs
Several birth cohort studies that included neurodevelopmental 
follow-up at school-age provide consistent evidence that pre-
natal exposure to OPs is associated with reduced IQ scores in 
children. In two birth cohorts, the concentrations of urinary 
dialkyl metabolites in pregnant women were measured and 
found to correspond roughly to the upper half of the distribu-
tion of values in pregnant US women. Bouchard et al. [79] re-
ported that a 10-fold increase in total urinary dialkyl phosphate 
metabolites was associated with a 5.6 point loss in full-scale 
IQ, while Engel et al. [80] reported that a 10-fold increase was 
associated with a loss of 1.4 points. Rauh et al. [81] measured 
the OP chlorpyrifos in umbilical cord blood plasma in an ur-
ban cohort and found that children’s IQ scores at 7 years of 
age declined 1.4 points for each standard deviation increase in 
concentration. 
Higher levels of OP metabolites have also been linked to 
an increased risk of ADHD [82] or parent-reported ADHD-re-
lated behaviors and performance on a continuous performance 
test [83]. Rauh et al. [84] conducted structural MRI studies on 
a subset of their New York City cohort. Children with prenatal 
exposures to chlorpyrifos in the upper tertile of the distribution 
showed evidence of white matter pathology, cortical thinning, 
and alterations in the usual sexual dismorphisms in brain mor-
phology.
Though the number of studies is limited, the evidence is 
persuasive that prenatal exposure to OPs at levels of exposure 
that are prevalent in the general population is detrimental to 
children’s neurodevelopment. Many details about the relation-
ship remain to be clarified, but given the prevalence of prenatal 
exposures that have been linked to adverse outcomes, addition-
al research on this topic is clearly warranted. Chemicals and Children’s Neurodevelopment
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Conclusion
For some chemicals, higher prenatal exposures have clearly 
and conclusively been linked to postnatal expressions of neu-
rotoxicity. For others, it is evident that the literature is inchoate, 
containing study findings that, at this stage, are difficult to rec-
oncile or integrate. For some of the chemicals, it is exceedingly 
challenging to characterize exposure due to short biological 
residence times (e.g., OPs, BPA) or the complexity of chemi-
cal class (e.g., PDBEs). The literatures on lead and arsenic 
illustrate the importance of conducting prospective studies 
that involve suitably extended follow-up, despite the substan-
tial logistical obstacles involved in doing so, as subtle impacts 
might not be evident using the relatively crude assessment tools 
that are available for use in infancy. Moreover, as noted earlier, 
pregnant women are not exposed to single chemicals but to 
complex mixtures. It is difficult enough to characterize the neu-
rotoxicity of exposure to single chemicals, but sooner or later, 
we will have to develop strategies for tackling the issue of inter-
actions that more closely reflect real-world exposures. 
The speed of any reconciliation of apparent conflicts in 
findings among studies would be facilitated if investigators 
designed studies so that the findings could be compared more 
easily. For some chemicals, this would involve reaching consen-
sus on whether the best exposure measure is a biomarker or the 
concentration in an environmental medium (e.g., manganese, 
arsenic), whether exposure is expressed in terms of the indi-
vidual chemical, classes of chemical (e.g., phthalates, PBDEs), 
and whether the most appropriate biomarker of exposure is 
concentration of the parent chemical or of a metabolite (e.g., 
OPs). Comparison among studies would also be facilitated if 
common endpoints were assessed at the same developmental 
stages, preferably using the same assessment tools and adjusting 
for standard sets of covariates. The value of coordinating stud-
ies in this way is illustrated by the pooled analyses that were 
carried out combining data from several international prospec-
tive studies of lead neurotoxicity [35]. By pursuing such coor-
dination to the extent possible, the amount of time needed to 
discern coherent signals in the evidence available for a chemical 
or class of chemical could be reduced, permitting more timely 
formulation of appropriate public health measures.
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